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Egyptian womenAbstract Background: Sexuality has rarely been studied in Chronic Obstructive Pulmonary
Disease female patients, nonetheless they do report several in dysfunction in their sexual life con-
sequent to fear of pain, breathlessness or shortness of breathing and exacerbation. Hence, leading
unsatisfactory sexual life.
Objective: To assess the effect of Chronic Obstructive Pulmonary Disease on sexual functions of
female patients at Suez Canal University Hospital as compared to healthy women.
Patients and methods: The sample consisted of two groups each of 86 female subjects, with most
common aged group from 30 to 40 respectively. The study group suffered Chronic Obstructive
Pulmonary Disease and fulﬁlled the inclusion criteria. The comparison group was healthy women
who were free of any pulmonary disease. Two instruments were used for data collection. The ﬁrst to
assess socio-demographic features of the two groups and the second to assess sexual functioning
and satisfaction.
Results: Socio-demographics revealed the following: Education level ranged from illiterate to
university graduate in both groups and more than one third of the sample were working in dusty
places. Body mass index of both groups showed over-weight measures in 87.2% of the study group
and 79.1% of the other group with no statistical difference. Positive history of gynecological prob-
lems in both groups was 73.1% and 72% respectively. Reported sexual dysfunctions by female
patients were statistically signiﬁcantly different at (P< 0.05) as compared with the healthy group.
Breathing disturbances interrupting sexual intercourse among the study group included: difﬁcult
breathing 91.9%, breathlessness 62%, fatigability 54%, particular sexual positions 97.6% and
reduced quality of sexual performance 96.9% while the comparison group’s breathing disturbances
interrupting sexual intercourse were 36.1%, 9.3%, 12.8%, 14%, 22.1% respectively. Results of
Sexual Function Index revealed a negatively signiﬁcant statistical difference between the study
and comparison groups at P< 0.001 with regard to scores of ‘‘desire and arousal, and also showedrculosis.
552 F.G. Abd-Elsalam et al.a negative signiﬁcant difference at P< 0.05 with regard to ‘‘sexual satisfaction’’. Correlation of the
Spirometry biological test ‘‘Forced Expiratory Volume in one second (FEV1) of the study group
with regard to ‘‘desire, arousal and sexual satisfaction was positively statistically signiﬁcant at
(P< 0.05) i.e., powerful breezing is positively correlated with desire, arousal, and sexual satisfac-
tion.
Conclusion: Signiﬁcant dysfunction in sexual life as attributed to symptoms of breathing difﬁcul-
ties and difﬁcult sexual positions were found in a majority of the studied Egyptian female group
with Chronic Obstructive Pulmonary Disease. Comparatively the healthy women group demon-
strated signiﬁcantly less sexual dysfunction.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a major
cause of chronic morbidity and mortality; it is currently the
fourth highest cause of death in the world, and is predicted
to be the third leading cause of mortality worldwide by the
year 2020 [1]. COPD is identiﬁed mainly according to the
‘‘Global Initiative for Chronic Obstructive Lung Disease’’
(GOLD) guidelines [2]. Spirometry measures the FEV1 and
FVC, as well as the FEV1/FVC ratio. These two tests measure
the severity of the disease. There is considerable evidence of
under diagnosis, especially in the mild and moderate groups
[3]. The clinical presentation, disease severity and progression
are quite heterogeneous and maybe the result of diverse patho-
genic processes that involve abnormalities in different patho-
genic pathways. Exacerbations of respiratory symptoms in
COPD are of major importance because of their profound
and long lasting adverse effects on patients [4]. Frequent epi-
sodes accelerate loss of lung function, affect the quality of life
of patients, and are associated with poor survival. Healthy sex-
uality is a fundamental part of human life. Sexual health not
only includes reproduction and the absence of disease or dys-
function, but also the ability of individuals to integrate their
sexuality into their lives.’’ ‘‘Sexual health is inextricably bound
to both physical and mental health.’’ [5]. But people with
COPD may worry about sex because they are afraid that they
will become too short of breath, or need to cough up phlegm.
COPD is a source of signiﬁcant disability in the function of
daily living sexuality and thereby the quality of sexual life
[6]. Although nurses feel responsible for providing sexual
counseling, they rarely do so in daily practice [7]. Possible rea-
sons for insufﬁcient sexual counseling are nurses lack time,
education, knowledge, skills and awareness. They may feel
uncomfortable discussing this subject; afraid that patients
might become upset, embarrassed, or offended when dis-
cussing sex; may be culturally inhibited.
Signiﬁcance of the study
As the researcher being a nurse herself at Suez Canal
University Hospital (SCUH), it became clear and imperative
to investigate the magnitude of the COPD distressing effects
on female patients’ healthy sexual functioning who receive
treatment at the out-patient Chest clinic of the (SCUH).
Therefor this study aims to assess the impact of COPD onsexual functioning of the affected female patients at (SCUH)
as compared with healthy group.Patients and methods
Study design and patients
This is a correlational exploratory study design to examine the
relationship between COPD and female patients’ sexual func-
tioning. Data were collected from December 2012 to the end of
May 2013, at Suez Canal University Hospital, Ismailia, Egypt.
The study was approved by the institutional ethics committees
and an oral approval from participants was obtained. An
accidental convenient sample of one hundred female patients
were recruited according to the inclusion criteria. During the
course of the study fourteen participants refused to continue
with the study. Hence the total number of the study sample
amounted to Eighty six female patients. The inclusion criteria
include: (a) sexually active married female patients suffering
from controlled mild, moderate or severe stable, (at least
6 months) Chronic Obstructive Pulmonary Disease (COPD)
and receiving topical treatments not interfering with sexual
functioning. (b) Age between 20 and 50 years old and still with
regular menstrual cycles. Exclusion criteria: (a) Patients receiv-
ing treatment for hepatic, hypertensive, cardiovascular,
hematological, renal and endocrine diseases. (b) Health condi-
tions that may affect female sexual functioning such as preg-
nancy, or gynecological problems. On the other hand
systemic disorders that may affect female sexual function were
also excluded e.g. hormonal, musculogenic or neurogenic dis-
eases. (c) Patients receiving antidepressant, antihypertensive
medications, or other drugs interfering with sexual function-
ing. (d) Postmenopausal patients whether receiving oral or
vaginal estrogen therapy. The Comparison group is also an
accidental/convenient sample of adult females, age between
20 and 50 years old, free of COPD. Their number was equiva-
lent to the study group and amounted to 86 females. The
comparison group was healthy women following the inclusion
and exclusion criteria. Three self-rating questionnaires were
used for data collection of this study ﬁlled voluntarily and
anonymously by the respondents by both the study and
comparison groups. The ﬁrst two tools were developed by the
researcher after reviewing the literature by Skrzypulec et al.
[8], Kaptein et al. [9], GOLD (2014). While the third one is a
standardized tool titled the ‘‘Female Sexual Function Index’’
Figure 1 A portable vitalograph copd-6 (Spirometry).
Table 1 Frequency and percentage distribution of subjects’ in
relation to socio-demographic characteristics.
Variables Study Comparison
group
X2 p
N 86 % N 86 %
Age 1.71
630 Years 12 14.0 14 16.2
31–40 years 36 41.9 41 47.6 NS
41–50 years 32 37.1 28 32.5
51 years 6 7.0 3 3.4
Education
Not reading/writing 32 37.2 10 11.62 4.7
Primary 22 25.58 18 20.9
Secondary 15 17.44 30 34.88 NS
University 17 19.77 28 32.56
Table 2 Frequency and Percentage distribution of subjects in
relation to BMI.
Variables Study
group
Comparison
group
X2 P
N 86 % N 86 %
BMI degree
Under weight 1 1.2 0 0.0 3.6 NS
Normal 10 11.6 18 20.9 NS
Over weight 75 87.2 68 79.1
Chronic Obstructive Pulmonary Disease and sexual functioning 553original by Rosen et al. [10] and Arabic version by Anis et al.
[11]. Developed tools were revised for face and content validity
by a panel of four experts from chest nursing specialty, chest
medical ﬁeld, and two professors one of Psychiatric medicine
and the other from Psychiatric Nursing. The ﬁrst tool is the
socio-demographic and health condition. The second tool is
The Speciﬁc COPD Female Sexual Function Index. The ﬁrst
tool includes age, level of education, job, body mass index,
smoking, patient past medical history, patient’s knowledge
about COPD and its management. The second tool is a three
point rating scale measuring detriments of successful sexual
acts (6 Items.) The third tool is the Arabic version of the
Female Sexual Function Index (FSFI). The FSFI is a stan-
dardized self-evaluation Inventory and a locally accepted tool
for use in the assessment of female sexual dysfunction in the
Egyptian population. It tests 6 domains: Desire (2 items),
Arousal (4 items), Lubrication (4 items), Orgasm (3 items),
Sexual Satisfaction (3 items), Pain (3 items. FSFI Scoring
System:
Score range 0-2 0-2 0-2 0-2 0-2 0-2
Factor *0 .6 *0 .3 *0 .3 *0 .4 *0 .4 *0 .4
Minimum 0 0 0 0 0 0 0
Maximum 6.6 1.8 1.2 2.4 1.6 1.6 15.2
It should be noted that within the individual domain, a
domain score of zero indicates that the subject reported having
no sexual activity during the past month while a score of two
indicates positive sexual function in addition to the use of
Spirometry to classify COPD severity (mild, moderate or sev-
ere) to Classify of the COPD severity (mild, moderate or sev-
ere) the measure of FEV1% [alone] which specifies the normal
measures as a ratio of less than 0.7’’ post Bronchodilator while
less measure indicates severity. This test was combined with a
history of exposure to risk factors.
Statistical analysis
Statistical differences were determined by using an analysis of
variance (ANOVA) and Student’s t-test using Microsoft Excel
software. Data were then imported into Statistical Package for
the Social Sciences (SPSS version 20.0) software for analysis.
Results were expressed as mean ± standard deviation of the
mean (SD). Qualitative data were compared using either Chi
square test. The probability (P value) was considered signiﬁ-
cant if P value was <0.05, highly signiﬁcant if P value was
<0.01 and P value <0.001, and insigniﬁcant if P value
was >0.05. The relationship between the studied measures
was assayed by Pearson’s linear correlation coefﬁcient.
Pearson correlation is considered negligible if r< 0.2, weak
if between 0.2 and 0.4, moderate if between 0.4 and 0.7 and
strong if r> 0.7.
Results
The present study was carried out in Suez Canal University
Hospital during the period of December 2012 to the end of
May 2013. Eighty six COPD female patients (Group I) were
included in our study in addition to 86 healthy females as a
comparison group (Group II) (Fig. 1).Table 1 shows a non-signiﬁcant difference between the
study and comparison groups regarding age an education.
Table 2 shows a non-signiﬁcant difference between study
and comparison groups regarding BMI.
Table 3 shows no-signiﬁcant difference between study and
comparison groups regarding gynecological problems.
Table 4 shows that 58.1% of patients had moderate exacer-
bations while (17.4%) of patients had severe exacerbations
more than 2 times/w, and the mild was 24.4%.
Table 5 and Fig. 2 show statistically signiﬁcant differences
at P< 0.05 between cases and comparison groups regarding
Table 5 negative effects of COPD on sexual functions of the
study group as compared to the comparison.
Variables Study
group
Comparison
group
X2 P
N 86 % N 86 %
Diﬃcult breathing not interrupting sexual
intercourse
7.4 <0.05
Sever 44 50.4 12 14
Moderate 35 41.5 19 22.1
Mild 7 81 55 64
Breathing diﬃculties interrupt sexual intercourse
Not concerned 23 26.7 69 80.2 8.6 <0.05
Yes 53 62 8 9.3
No 10 11.7 9 10.5
Fatigue interrupts intercourse
Not concerned 28 32.5 69 80.2 12.9 <0.05
Yes 46 54 11 12.8
No eﬀect 12 13.9 6 7.0
Diﬃcult breathing in particular sex positions
Yes 59 70.2 3 3.5 7.9 <0.05
Sometimes 23 27.4 9 10.5
No 2 2.4 74 86.5
Diﬃcult breathing aﬀects physical sexual performance
Yes 55 65.5 5 5.8 22.6 <0.001
Sometimes 27 31.4 14 16.3
No 4 3.6 67 77.9
Table 3 Frequency and Percentage distribution of subjects in
relation to gynecological history.
Variables Study
group
Comparison
group
X2 P
value
N
86
% N 86 %
Gynecological history
Natural delivery 56 65.4 58 67.4 0.03 NS
Vaginal inﬂammation 17 19.7 18 21 0.04
Other gynecological
diseases
46 53.4 44 51 0.03
Figure 2 Comparison between cases and controls regarding
difﬁcult breathing during orgasm.
Table 6 Comparison of Sexual Function Index between the
study and comparison groups.
Variables x± SD t-test P
Desire
Study 1.2 ± 0.67 4.682- <0.001
Comparison group 1.72 ± 0.55
Arousal
Study 0.9 ± 0.42 4.272* <0.001
Comparison group 1.3 ± 0.42
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difﬁculties interrupting sexual intercourse, fatigue interrupting
sexual intercourse and difﬁcult breathing in particular sex posi-
tions. The table also shows a highly signiﬁcant difference at
P< 0.001 regarding difﬁcult breathing during orgasm and dif-
ﬁcult breathing affecting physical sexual performances.
Table 6 shows highly signiﬁcant differences at P< 0.001
between the study and comparison groups regarding desire,
arousal and orgasm scores and also shows a signiﬁcant differ-
ence at P< 0.05 regarding sexual satisfaction and pain while
no-signiﬁcant difference was there between them regarding
lubrication.
Table 7 shows no-signiﬁcant correlation between BMI and
each of the Sexual Functioning in COPD group. Signiﬁcant
positive correlation is found between the FEV1% and desire,
arousal, orgasm and satisfaction.
Table 8 shows non-signiﬁcant correlations between BMI
and Sexual Functioning of the comparison group.
Discussion
A woman’s sexuality is a complex interplay of physical and
emotional responses that affect the way she thinks and feels
about herself. When a woman has a sexual problem, it can
impact many aspects of her life [12]. Pulmonary disease can
impair sexual functioning. The medications used to alleviate
the disease can both help and hinder sexual functioning [13].
The present study was performed to assess the effect of
COPD on female sexual functioning as compared to healthy
women. It can be observed from the present study that
nearly half of both cases in the study and comparison
groups had ages between 31 and 40 years which indicate
the high prevalence of the COPD among this age group
who are supposed to be sexually active and plan for repro-
duction. Results in similar studies [14] are consistent withTable 4 Frequency and Percentage distribution of subjects in
the study group in relation to exacerbations.
Variables Study group
N 86 %
Exacerbations
One time/week 21 24.4
From 1 to 2 weeks 50 58.1
More than 2 t/w 15 17.4
Lubrication
Study 0.48 ± 0.217 1.911 NS
Comparison group 0.54 ± 0.188
Orgasm score
Study 1.02 ± 0.45 4.093* <0.001
Comparison group 1.31 ± 0.46
Sexual satisfaction
Study 1.08 ± 0.42 2.519* <0.05
Comparison group 1.29 ± 0.47
Pain
Study 0.42 ± 0.1.2 2.2 <0.05
Comparison group 0.37 ± 0–1.2
Table 7 Correlations between Weight, Height, BMI and FEV 1% and of the Sexual Functioning of the study group.
Variables Desire Arousal Lubrication Orgasm score Satisfaction score Pain
BMI .098- .023 .039 .013 .037 .084-
FEV1% .226
* .219* .103 .278* .242* .056-
Table 8 Correlations between BMI and Sexual Functioning of the comparison group.
Variables Desire Arousal Lubrication Orgasm score Satisfaction score Pain
BMI .015 .031- .081 .000 .152 .047-
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to affect individuals in their third decade during their peak
productivity and still desiring sexual life. Results of the
Body Mass Index (BMI), of the study group showed that
over three quarters of them are overweight. This observation
can be related to their use of corticosteroid therapy, or the
unhealthy nutritional habits as many of them admitted tak-
ing heavy meals even before sexual intercourse. Conversely
other studies [15,16] reported that weight loss is a common
feature in patients with COPD which has an adverse effect
on physical performance and QoL. These authors also
explained that weight loss is an unfavorable prognostic fac-
tor in survival and lung function and is considered the result
of imbalance between energy intake and increase energy
expenditure due to increase work of breathing. Another
result clariﬁed that more than three quarters of the study
group had both moderate and severe exacerbations of
COPD that required treatment by a physician while only
one quarter of the cases had mild exacerbations. This high-
lights that the COPD patients’ disease was controlled in
most of study samples by medications at the out-patient
clinic. Notably, this result assures that COPD patients with
exacerbation can still live their sexual life and receive treat-
ment at home [17]. This study showed that COPD female
patients did suffer signiﬁcant dysfunction in their sexual
functioning as compared to the healthy women in the com-
parison group. This signiﬁcant difference between the study
and comparison groups was found in most of the domains
of the developed assessment tool (the Speciﬁc COPD
Female Functioning Index) namely breathing disturbances
that do not interrupt intercourse at p 6 0.05 among half
of the study group who complained of severe breathing dis-
turbances during sexual intercourse compared to the com-
parison group whose number was less than one quarter of
the samples. This result is in agreement with Kaptein et.al.
[9] who found that patients with chronic chest disease has
signiﬁcantly higher impaired sexual life compared with
healthy ones and that COPD patients had higher sexual dys-
function than other chest diseases. In addition, signiﬁcant
differences were found between the study and comparison
groups at p 6 0.05 with regard to both breathing difﬁculties
and rapid fatigability leading to interruption of sexual inter-
course. More than half of the study group complained of
breathing difﬁculties during sexual intercourse compared to
the comparison group whose number amounted to less than
one tenth of the samples. The complaint of interruption ofsexual intercourse due to rapid fatigue was more than half
of the study group compared to less than one quarter of
the comparison group.
According to the Sexual Function Index nearly half of the
study group had occurrence of difﬁcult breathing during
orgasm with a highly signiﬁcant difference at (p 6 0.001) com-
pared to the comparison group. These results reﬂect the impact
of COPD disease on the sexual dysfunction observed with
cases throughout the different stages of sexual performances
reaching to orgasm. This view is also detected in studies about
sexual hampering in COPD patients [18,19].
The COPD effects on sexual performances were noticed
also in sensation of difﬁcult breathing at particular sexual posi-
tions leading to inability to complete sex performances in a
comfortable way. Nearly three quarters of the study group
complained of the occurrence of difﬁcult breathing in particu-
lar sex positions compared to the comparison group while a
majority of the comparison group considered this issue as
negligible with a statistical difference at P 6 0.05. Also nearly
about three quarters of the study group complained of
impaired mobility related to breathing difﬁculties as compared
to the comparison group, leading to inability to complete sex
performances. The majority of the comparison group denied
its occurrence at P 6 0.001. These results are in agreement
with [20,21]. who found that, patients with COPD had poor
sexual activities, as well as poor psycho-social functions and
in performing physical activities. They also afﬁrmed that sex-
ual dysfunction increases with increase in the severity COPD
and shows that FEV1% had a signiﬁcant positive correlation
with desire, arousal, orgasm, and satisfaction which means
that with increase in the severity of COPD the sexual function
decreases (indicated by lower FSFI score). On the other hand
the present study results show a non-signiﬁcant correlation
between each of the BMI and each of the sexual functions in
both study and comparison groups. The present study results
go along with Skrzypulec et.al. [8] Lloyd et.al. [22] and
Porsbjerg et.al. [23] whose ﬁndings reported that sexual dys-
functions increase with increasing severity of the COPD
disease.
Conclusion
Chronic Obstructive Pulmonary Disease has a negative impact
on the quality of sexual functions of female patients at Suez
Canal University Hospital leading to a disordered sexual life
as compared to healthy women.
556 F.G. Abd-Elsalam et al.Recommendation
Health teaching and educational materials such as illustrated
booklets must be offered for female COPD patients by
trained nurses to provide them with information about more
comfortable sexual positions for respiratory problems, and
how to improve their knowledge, to improve sexual functioning
and achieve satisfaction in their sexual life without fear of
breathing difﬁculties.
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